ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

HEMO Hemogenyx Pharmaceuticals Plc

1.585
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hemogenyx Pharmaceuticals Plc LSE:HEMO London Ordinary Share GB00BYX3WZ24 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.585 1.57 1.60 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 0 -3.98M -0.0035 -4.51 18.04M
Hemogenyx Pharmaceuticals Plc is listed in the Finance Services sector of the London Stock Exchange with ticker HEMO. The last closing price for Hemogenyx Pharmaceuticals was 1.59p. Over the last year, Hemogenyx Pharmaceuticals shares have traded in a share price range of 1.125p to 6.30p.

Hemogenyx Pharmaceuticals currently has 1,141,999,321 shares in issue. The market capitalisation of Hemogenyx Pharmaceuticals is £18.04 million. Hemogenyx Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.51.

Hemogenyx Pharmaceuticals Share Discussion Threads

Showing 1126 to 1146 of 13425 messages
Chat Pages: Latest  57  56  55  54  53  52  51  50  49  48  47  46  Older
DateSubjectAuthorDiscuss
31/1/2020
16:03
John, I really think you would have learned to be quiet now. You've all embarrassed yourselves.
davevt
31/1/2020
14:24
Dave raised good point.

I was thinking the same yesterday that why Andrew bought it only after placing.

Still no reply of my email!

marie1980
31/1/2020
14:01
Give it a rest Dave...

Go and find another share to doom and gloom...you bore us all...

johntopdog
31/1/2020
13:52
Anyone notice that a director only bought shares after a placing, and only 5 grands worth.

Doesn't give you much confidence eh.

Didn't think the shares were worth more than 2p, doesn't want to invest any decent money, and technically traded on insider information as he personally would have known this price drop was coming.

Not that you should take any notice of director deals anyway.....why? Because that director just got paid a load of money from said placing, it's not like the 5 grand he just spent came out of his own pocket, is it...

davevt
31/1/2020
10:47
I agree dave. I was annoyed with your constant negative comments here but slowly I'm getting what you mean there.

I'm also bit annoyed as Dr. and Andrew has so far not reply me. I chased them again as I type.

marie1980
31/1/2020
10:31
fully funded for the next 12 months.whats not to like?

waiting for the in vivo results from car t and cdx manufacturabilty results next......then IND ,then development/licensing agreements as we move into monkey testing/phase 1 trials.
most pharma cos trade at @40mcap going into phase 1 trials

all to play for!

8-12p

purple11
31/1/2020
09:55
fully funded for the next 12 months.whats not to like?

waiting for the in vivo results from car t and cdx manufacturabilty results next......then IND ,then development/licensing agreements as we move into monkey testing/phase 1 trials.
most pharma cos trade at @40mcap going into phase 1 trials

all to play for!

8-12p

purple11
31/1/2020
09:35
Well I did warn you Marie and you mocked me the other day, remember.?
davevt
31/1/2020
07:59
True renal, but amount he purchased is hardly confidence booster for the market. That’s the amount many of board members purchased to average down price.
I’m confident this is not the RNS lti need right now unfortunately

marie1980
31/1/2020
07:48
Always follow the financial directors purchases, a good sign methinks
renalrod
31/1/2020
07:17
Andrew bought HEMO share.
If I remember last time also he purchased worth £10,000
Not huge amount but he is the one accumulating.
Strange - I’m still awaiting reply from him about subsidiary. Usually he reply in a day!

marie1980
30/1/2020
21:53
Yes Dave, you're so great and finally mummy loves you.
on target
30/1/2020
20:03
filtered. complete idiot.
purple11
30/1/2020
16:52
and when they do we could be looking at massive upside.
purple11
30/1/2020
16:04
Indeed, and we need these discussions to come to a conclusion:

"Work on the core CDX antibody project with the Company's major pharmaceutical partner continues to progress with successful results achieved in further laboratory tests and with discussions ongoing as to its future development and funding."

on target
30/1/2020
16:01
Not so bad considering that we are trading at a premium to the new issue price.......and the company has circa 650k working capital. It's now up to Dr. Sandler to push CDX to the next level.
badger60
30/1/2020
14:23
You're welcome Badger,

I've also included Andrew Wright ( CFO ) as previously he is the one who also give fast response.

FYI, if you need details of their email:

From: XXX
Sent: 30 January 2020 06:17
To: 'headquarters@hemogenyx.com' ; 'vladislav.sandler@hemogenyx.com' ; 'andrew.wright@hemogenyx.com'

Subject: Subsidiary and concerns regarding Hemo's financial


Let's be honest, so far Dave has been right in a way that HEMO has not achieved as we would have liked or as much as they promised earlier. Still there is no IND or even Phase1 trials.

I re-read the RNS about £75K and i also put the concerns that agreement was with Immugenyx and why not with HEMO ?

I've recently added more HEMO in my portfolio but now Dave has put some doubt in my thought process.

Again, I will keep you posted about Dr/Andrew's email. I also requested them if I can meet them should they are in London next time. Again will keep you updated.

Best,

marie1980
30/1/2020
14:15
to provide additional working capital for the Company to progress its core CDX antibody collaboration and to support its various partnerships with other major pharmaceutical companies.
purple11
30/1/2020
14:14
Fundraising done and dusted - Dave will have to close his short now.
on target
30/1/2020
14:12
gone to good hands progress excellent
tsmith2
30/1/2020
14:11
Work on the core CDX antibody project with the Company's major pharmaceutical partner continues to progress with successful results achieved in further laboratory tests and with discussions ongoing as to its future development and funding
purple11
Chat Pages: Latest  57  56  55  54  53  52  51  50  49  48  47  46  Older

Your Recent History

Delayed Upgrade Clock